Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis-Reference-Cited by-同舟云学术

Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis

Published:1999-06 Issue:6 Volume:29 Page:1768-1778
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Levy Miriam T.,McCaughan Geoffrey W.,Abbott Catherine A.,Park John E.,Cunningham Anne M.,Müller Erika,Rettig Wolfgang J.,Gorrell Mark D.

Funder

Australian National Health and Medical Research Council (NHMRC) (to G.W.M., M.D.G.)

NHMRC postgraduate scholarship (to M.T.L.)

Garnett Passe and Rodney Williams Memorial Foundation (to A.M.C.)

Publisher

Wiley

Subject

Hepatology

Reference64 articles.

1. Fibroblast activation protein: purification, epitope mapping and induction by growth factors;Rettig;Int J Cancer,1994

2. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers;Scanlan;Proc Natl Acad Sci U S A,1994

3. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets;Rettig;Cancer Res,1986

4. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells;Rettig;Proc Natl Acad Sci U S A,1988

5. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers;Garin-Chesa;Proc Natl Acad Sci U S A,1990

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis;Inflammopharmacology;2024-08-21

2. 68Ga-DOTA.SA.FAPi PET in Response Assessment After 177Lu-Microspheres Selective Intra-arterial Radionuclide Therapy for Unresectable Hepatocellular Carcinoma;Clinical Nuclear Medicine;2024-07-31

3. Development and validation of a novel circulating fibroblast activation protein - based predictive model to improve fibrosis risk stratification in metabolic liver disease population;2024-07-22

4. Recent Clinical Implications of FAPI;Clinical Nuclear Medicine;2024-07-18

5. Efficacy and safety evaluation of cross-reactive Fibroblast activation protein scFv-based CAR-T cells;Frontiers in Immunology;2024-07-17